Mather Group’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-64
Closed -$1.89K – 2252
2026
Q2
$1.89K Hold
64
– – ﹤0.01% 1744
2026
Q1
$1.5K Buy
+64
New +$1.16K ﹤0.01% 1732
2025
Q4
– Sell
-116
Closed -$2.87K – 650
2025
Q3
$2.87K Buy
+116
New +$2.59K ﹤0.01% 1491
2025
Q2
– Sell
-390
Closed -$11.8K – 621
2025
Q1
$11.8K Sell
390
-189
-33% -$7.2K ﹤0.01% 1206
2024
Q4
$23K Buy
579
+12
+2% +$541 ﹤0.01% 1052
2024
Q3
$36K Sell
567
-60
-10% -$4.33K ﹤0.01% 945
2024
Q2
$49.7K Buy
627
+4
+0.6% +$279 ﹤0.01% 1000
2024
Q1
$48.4K Buy
+623
New +$50.9K ﹤0.01% 881

Other funds holding ACHC

Mather Group's ACHC Position: Q3 2026 in Review

Mather Group sold out of Acadia Healthcare (ACHC) in Q3 2026, closing a stake of 64 shares — an estimated $1.89K sold.

Mather Group first reported a position in ACHC in Q1 2024 and held it in 8 quarters. The position peaked at $49.7K in Q2 2024. 37 funds tracked by Wall St. Rank hold ACHC as of Q3 2026.

  • Mather Group reported no remaining Acadia Healthcare position as of Q3 2026 after selling out during the quarter.
  • Mather Group sold 64 Acadia Healthcare shares in Q3 2026, an estimated $1.89K.
  • Mather Group first reported a position in Acadia Healthcare in Q1 2024 and held it in 8 quarters.
  • Mather Group's Acadia Healthcare position peaked at $49.7K in Q2 2024.
  • 37 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.